U.S. market Closed. Opens in 12 hours 6 minutes

EHC | Encompass Health Corporation Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for EHC we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is moderate, Growth is good and Health is weak.

Valuation (50%)

Company Industry
P/E Ratio (TTM) 22.84 28.90
PEG Ratio (TTM) 14.17 4.28
P/S Ratio (TTM) 1.81 1.88
P/B Ratio (TTM) 4.96 -23.53
P/FCF Ratio (TTM) 44.43 17.57
Price to 5YR AVG Earnings Ratio 26.90 24.46
Price to 5YR AVG FCF Ratio 47.45 22.95

Profitability (60%)

Company Industry
ROA (TTM) 6.25% 5.81%
ROE (TTM) 23.54% -95.85%
Net Profit Margin (TTM) 7.88% -1.38%
ROIC 5YR AVG 14.50% 16.52%

Growth (65%)

4QTR AVG 3YR AVG 5YR AVG
EPS 6.25% 203.25% 109.67%
Revenue 2.35% -22.42% 47.22%
Net Income 6.47% -16.26% 25.01%
Cash Flow 1.84% -23.43% 84.54%

Health (47%)

Company Industry
Current Ratio (TTM) 1.35 1.32
Quick Ratio (TTM) 1.35 1.17
D/E Ratio (TTM) 1.32 -8.38
Interest Coverage (TTM) 5.19 16.37
Piotroski F-Score 7 7
Altman Z-Score 2.75 3.11
LTL to 5YR AVG FCF 12.24 7.50
Shares Outstanding Growth 5YR AVG 469.77% 17.91%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙